APIC guideline for selection and use of disinfectants

American Journal of Infection Control

Volumn 24, Issue 4, 1996, Pages 313-342

  Rutala, William A ^a,b,c,d  

^a Association for Infection Control and Epidemiology Inc   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^d APIC National Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BENZALKONIUM CHLORIDE; FORMALDEHYDE; GLUTARALDEHYDE; HYDROGEN PEROXIDE; HYPOCHLORITE; IODINE; PARAFORMALDEHYDE; PERACETIC ACID; PHENOL;

DENTAL EQUIPMENT; DISINFECTION; ENDOSCOPE; INSTRUMENT STERILIZATION; LAPAROSCOPY; MEDICAL INSTRUMENTATION; REVIEW; SURGICAL EQUIPMENT; TONOMETRY;

EID: 0029738949     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(96)90066-8     Document Type: Article

References (294)

1. Simmons BP. Guideline for hospital environmental control. AJIC Am J Infect Control 1983;11:97-115.
2. Garner JS, Favero MS. Guideline for handwashing and hospital environmental control, 1985. AJIC Am J Infect Control 1986;14:110-26.
3. Rutala WA. Disinfection, sterilization and waste disposal. In: Wenzel RP, ed. Prevention and control of nosocomial infections. Baltimore: Williams and Wilkins, 1987:257-82.
4. Rutala WA. Disinfection, sterilization and waste disposal. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams and Wilkins, 1993:460-95.
5. Rutala WA. APIC guideline for selection and use of disinfectants. AJIC Am J Infect Control 1990;18:99-117.
6. Rutala WA. Selection and use of disinfectants in health care. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams and Wilkins, 1995: 913-36.
7. Rutala WA, Cole EC. Ineffectiveness of hospital disinfectants against bacteria: a collaborative study. Infect Control 1987;8:501-6.
8. Myers T. Failing the test: germicides or use-dilution methodology? ASM News 1988;54:19-21.
9. Robison RA, Bodily HL, Robinson DF, Christensen RP. A suspension method to determine reuse life of chemical disinfectants during clinical use. Appl Environ Microbiol 1988;54:158-64.
10. Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:617-41.
11. Spaulding EH. Chemical disinfection of medical and surgical materials. In: Lawrence CA, Block SS, eds. Disinfection, sterilization and preservation. Philadelphia: Lea & Febiger, 1968:517-31.
12. Bean HS. Types and characteristics of disinfectants. J Appl Bacteriol 1967;30:6-16.
13. Russell AD. Factors influencing the efficacy of antimicrobial agents. In: Russell AD, Hugo WB, Ayliffe GAJ, eds. Principles and practice of disinfection, preservation and sterilisation. Oxford: Blackwell Scientific Publications, 1992:89-113.
14. Centers for Disease Control. Guidelines for the prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(S-6):1-37.
15. Rutala WA, Weber DJ. FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect Control Hosp Epidemiol 1995;16:231-5.
16. Lewis DL, Arens M. Resistance of microorganisms to disinfection in dental and medical devices. Nature Medicine 1995;1:1-3.
17. Parker HH IV, Johnson RD. Effectiveness of ethylene oxide for sterilization of dental handpieces. J Dent 1995;23:113-5.
18. Muscarella LF. Sterilizing dental equipment. Nature Medicine 1995;1:1223-4.
19. Block SS. Definition of terms. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:18-25.
20. Food and Drug Administration, Public Health Service, Environmental Protection Agency. Memorandum of understanding between the Food and Drug Administration, Public Health Service, and the Environmental Protection Agency. Washington, DC: PDA, PHS, EPA, June 4 1993.
21. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. AJIC Am J Infect Control 1995;23:251-69.
22. Rutala WA, Clontz EP, Weber DJ, Hoffmann KK. Disinfection practices for endoscopes and other semicritical items. Infect Control Hosp Epidemiol 1991;12:282-8.
23. Martin MA, Reichelderfer M. APIC guideline for infection prevention and control in flexible endoscopy. AJIC Am J Infect Control 1994;22:19-38.
24. Society of Gastroenterology Nurses and Associates. Recommended guidelines for infection control in gastrointestinal endoscopy settings. Rochester, N.Y.: SGNA, 1990.
25. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonei causing otitis media in an ear-nose-and-throat practice. N Engl J Med 1988;319:978-82.
26. Meenhorst PL, Reingold AL, Groothuis DG, et al. Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis 1985;152: 356-64.
27. Gerding DN, Peterson LR, Vennes JA. Cleaning and disinfection of fiberoptic endoscopes: evaluation of glutaraldehyde exposure time and forced-air drying. Gastroenterology 1982;83:613-8.
28. Alfa MJ, Sitter DL. In-hospital evaluation of contamination of duodenoscopes: a quantitative assessment of the effect of drying. J Hosp Infect 1991;19:89-98.
29. Weber DJ, Rutala WA. Environmental issues and nosocomial infections. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams and Wilkins, 1993:420-49.
30. Sattar SA, Lloyd-Evans N, Springthorpe VS. Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg 1986;96:277-89.
31. National Institute for Occupational Safety and Health. Formaldehyde: evidence of carcinogenicity. NIOSH current intelligence bulletin 34. DHEW (NIOSH) publication no 81-111. Washington, DC: NIOSH, April 15 1981.
32. Occupational Safety and Health News. OSHA amends formaldehyde standard. Sept. 1991:1.
33. Sarin PS, Scheer DI, Kross RD. Inactivation of human T-cell lymphotropic retrovirus (HTLV-III) by LD [letter]. N Engl J Med 1985;313:1416.
34. Terleckyj B, Axler DA. Quantitative neutralization assay of fungicidal activity of disinfectants. Antimicrob Agents Chemother 1987;31:794-8.
35. Korich DG, Mead JR, Madore MS, Sinclair NA, Sterling CR. Effects of ozone, chlorine dioxide, chlorine, and monochloramine on Cryptosporidium parvum oocyst viability. Appl Environ Microbiol 1990;56:1423-8.
36. Russell AD. Bacterial spores and chemical sporicidal agents. Clin Microbiol Rev 1990;3:99-119.
37. Mbithi JN, Springthorpe VS, Sattar SA. Chemical disinfection of hepatitis A virus on environmental surfaces. Appl Environ Microbiol 1990;56:3601-4.
38. Klein M, DeForest A. The inactivation of viruses by germicides. Chem Specialists Manuf Assoc Proc 1963; 49:116-8.
39. Rutala WA, Cole EC, Wannamaker NS, Weber DJ. Inactivation of Mycobacterium tuberculosis and Mycobacterium bovis by 14 hospital disinfectants. Am J Med 1991;91(3B):267S-71S.
40. Isenberg HD, Giugliano ER, France K, Alperstein P. Evaluation of three disinfectants after in-use stress. J Hosp Infect 1988;11:278-85.
41. Cole EC, Rutala WA, Nessen L, Wannamaker NS, Weber DJ. Effect of methodology, dilution, and exposure time on the tuberculocidal activity of glutaraldehyde-based disinfectants. Appl Environ Microbiol 1990;56:1813-7.
42. Best M, Sattar SA, Springthorpe VS, Kennedy ME. Efficacies of selected disinfectants against Mycobacterium tuberculosis. J Clin Microbiol 1990;28:2234-9.
43. Power EGM, Russell AD. Sporicidal action of alkaline glutaraldehyde: factors influencing activity and a comparison with other aldehydes. J Appl Bacteriol 1990;69: 261-8.
44. Best M, Kennedy ME, Coates F. Efficacy of a variety of disinfectants against Listeria spp. Appl Environ Microbiol 1990;56:377-80.
45. Tyler R, Ayliffe GAJ, Bradley C. Virucidal activity of disinfectants: studies with the poliovirus. J Hosp Infect 1990;15:339-45.
46. Rutala WA, Gergen MF, Weber DJ. Inactivation of Clostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 1993;14:36-9.
47. Rutala WA, Gergen MF, Weber DJ. Sporicidal activity of chemical sterilants used in hospitals. Infect Control Hosp Epidemiol. 1993;14:713-8.
48. Ascenzi JM, Ezzell RJ, Wendt TM. A more accurate method for measurement of tuberculocidal activity of disinfectants. Appl Environ Microbiol 1987;53:2189-92.
49. Collins FM. Use of membrane filters for measurement of mycobactericidal activity of alkaline glutaraldehyde solution. Appl Environ Microbiol 1987;53:737-9.
50. Collins FM. Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species. J Appl Bacteriol 1986;61:247-51.
51. Collins FM. Kinetics of the tuberculocidal response by alkaline glutaraldehyde in solution and on an inert surface. J Appl Bacteriol 1986;61:87-93.
52. Crow S, Metcalf RW, Beck WC, Birnbaum D. Disinfection or sterilization? four views on arthroscopes. AORN J 1983;37:854-68.
53. Phillips J, Hulka B, Hulka J, Keith D, Keith L. Laparoscopic procedures: the American Association of Gynecologic Laparoscopists' membership survey for 1975. J Reprod Med 1977;18:227-32.
54. Loffer FD. Disinfection vs sterilization of gynecologic laparoscopy equipment: the experience of the Phoenix Surgicenter. J Reprod Med 1980;25:263-6.
55. Johnson LL, Shneider DA, Austin MD, Goodman FG, Bullock JM, DeBruin JA. Two percent glutaraldehyde: a disinfectant in arthroscopy and arthroscopic surgery. J Bone Joint Surg [Am] 1982;64:237-9.
56. Miles RS. What standards should we use for the disinfection of large equipment? J Hosp Infect 1991;18(Suppl A):264-73.
57. Centers for Disease Control. Recommendations for preventing possible transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from tears. MMWR 1985;34:533-4.
58. Lettau LA, Bond WW, McDougal JS. Hepatitis and diaphragm fitting. JAMA 1985;254:752.
59. Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-28.
60. Kaczmarek RG, Moore RM, McCrohan J, et al. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med 1992;92: 257-61.
61. Alvarado CJ, Stolz SM, Maki DG. Nosocomial infections from contaminated endoscopes: a flawed automated endoscope washer: an investigation using molecular epidemiology. Am J Med 1991;91(Suppl 3B):272S-80S.
62. Fraser VJ, Jones M, Murray PR, Medoff G, Zhang Y, Wallace RJ Jr. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonei linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis 1992;145:853-5.
63. Dwyer DM, Klein EG, Istre GR, Robinson MG, Neumann DA, McCoy GA. Salmonella newport infections transmitted by fiberoptic colonoscopy. Gastrointest Endosc 1987; 33:84-7.
64. Wheeler PW, Lancaster D, Kaiser AB. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J Infect Dis 1989;159:954-8.
65. Bond WW. Virus transmission via fiberoptic endoscope: recommended disinfection. JAMA 1987;257:843-4.
66. Lynch DAF, Porter C, Murphy L, Axon ATR. Evaluation of four commercial automatic endoscope washing machines. Endoscopy 1992;24:766-70.
67. Bond WW, Ott BJ, Franke KA, McCracken JE. Effective use of liquid chemical germicides on medical devices: instrument design problems. In: Block SS, ed. Disinfection, sterilization, and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:1097-106.
68. Working Party of the British Society of Gastroenterology. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy; interim recommendations of a Working Party of the British Society of Gastroenterology. Gut 1988;29:1134-51.
69. American Society for Gastrointestinal Endoscopy Position Statement. Reprocessing of flexible gastrointestinal endoscopes. Manchester, Mass. Dec. 1995.
70. Hanson PJV, Gor D, Jeffries DJ, Collins JV. Elimination of high titre HIV from fibreoptic endoscopes. Gut 1990; 31:657-9.
71. Hanson PJV, Gor D, Clarke JR, et al. Recovery of the human immunodeficiency virus from fibreoptic bronchoscopes. Thorax 1991;46:410-2.
72. Hanson PJV, Jeffries DJ, Collins JV. Viral transmission and fibreoptic endoscopy. J Hosp Infect 1991;18(Suppl A):136-40.
73. Vesley D, Norlien KG, Nelson B, Ott B, Streifel AJ. Significant factors in the disinfection and sterilization of flexible endoscopes. AJIC Am J Infect Control 1992;20: 291-300.
74. Babb JR, Bradley CR. Endoscope decontamination: where do we go from here? J Hosp Infection 1995;30: 543-51.
75. Ad Hoc Committee on Infection Control in the Handling of Endoscopic Equipment. Guidelines for preparation of laparoscopic instrumentation. AORN J 1980;32:65,66, 70,74,76.
76. Hulka JF, Wisler MG, Bruch C. A discussion: laparoscopic instrument sterilization. Med Instrumentation 1977;11:122-3.
77. Corson SL, Block S, Mintz C, Dole M, Wainwright A. Sterilization of laparoscopes: is soaking sufficient? J Reprod Med 1979;23:49-56.
78. Corson SL, Dole M, Kraus R, Richards L, Logan B. Studies in sterilization of the laparoscope: II. J Reprod Med 1979;23:57-9.
79. Craven ER, Butler SL, McCulley JP, Luby JP. Applanation tonometer tip sterilization for adenovirus type 8. Ophthalmology 1987;94:1538-40.
80. American Academy of Ophthalmology. Updated recommendations for ophthalmic practice in relation to the human immunodeficiency virus and other infectious agents. San Francisco: AAO, June 1992.
81. Pepose JS, Linette G, Lee SF, MacRae S. Disinfection of Goldmann tonometers against human immunodeficiency virus type 1. Arch Ophthalmol 1989;107:983-5.
82. Ventura LM, Dix RD. Viability of herpes simplex virus type 1 on the applanation tonometer. Am J Ophthalmol 1987;103:48-52.
83. Koo D, Bouvier B, Wesley M, Courtright P, Reingold A. Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments. Infect Control Hosp Epidemiol 1989;10:547-52.
84. Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993;167:1307-13.
85. Lewis DL, Arens M, Appleton SS, et al. Cross-contamination potential with dental equipment. Lancet 1992;340: 1252-4.
86. Lewis DL, Boe RK. Cross-infection risks associated with current procedures for using high-speed dental handpieces. J Clin Microbiol 1992;30:401-6.
87. American Dental Association. Infection control recommendations for the dental office and the dental laboratory. J Am Dent Assoc 1992;123:1-8.
88. Centers for Disease Control and Prevention. Recommended Infection-Control Practices for Dentistry, 1993. MMWR 1993;41(RR-8):1-12.
89. Department of Health and Human Services, Food and Drug Administration. Dental handpiece sterilization. Washington, DC: FDA, Sep 28 1992.
90. Miller CH. Cleaning, sterilization and disinfection: Basics of microbial killing for infection control. J Am Dent Assoc 1993;124:48-56.
91. Molinari JA, Gleason MJ, Cottone JA, Barrett ED. Comparison of dental surface disinfectants. Gen Dent 1987;May-June:171-5.
92. Bond WW, Favero MS, Petersen NJ, Ebert JW. Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol 1983;18: 535-8.
93. Kobayashi H, Tsuzuki M, Koshimizu K, et al. Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 1984;20:214-6.
94. Spire B, Montagnier L, Barre-Sinoussi F, Chermann JC. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 1984;8408:899-901.
95. Martin LS, McDougal JS, Loskoski SL. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 1985; 152:400-3.
96. Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 1986; 255:1887-91.
97. Centers for Disease Control. Recommendations for prevention of HIV transmission in health-care settings. MMWR 1987;36(Suppl):S3-18.
98. Prince DL, Prince RN, Prince HN. Inactivation of human immunodeficiency virus type 1 and herpes simplex virus type 2 by commercial hospital disinfectants. Chem Times Trends 1990;13:13-6.
99. Sattar SA, Springthorpe VS. Survival and disinfectant inactivation of the human immunodeficiency virus: a critical review. Rev Infect Dis 1991;13:430-47.
100. Kaplan JC, Crawford DC, Durno AG, Schooley RT. Inactivation of human immunodeficiency virus by Betadine. Infect Control 1987;8:412-4.
101. Hanson PJV, Gor D, Jeffries DJ, Collins JV. Chemical inactivation of HIV on surfaces. Br Med J 1989;298: 862-4.
102. Hanson PJV, Chadwick MV, Gaya H, Collins JV. A study of glutaraldehyde disinfection of fibreoptic bronchoscopes experimentally contaminated with Mycobacterium tuberculosis. J Hosp Infect 1992;22:137-42.
103. Prince DL, Prince HN, Thraenhart O, Muchmore E, Bonder E, Pugh J. Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol 1993;31:3296-304.
104. Reynolds CD, Rhinehart E, Dreyer P, Goldmann DA. Variability in reprocessing policies and procedures for flexible fiberoptic endoscopes in Massachusetts hospitals. AJIC Am J Infect Control 1992;20:283-90.
105. Handsfield HH, Cummings MJ, Swenson PD. Prevalence of antibody to human immunodeficiency virus and hepatitis B surface antigen in blood samples submitted to a hospital laboratory: implications for handling specimens. JAMA 1987;258:3395-7.
106. Baker JL, Kelen GD, Sivertson KT, Quinn TC. Unsuspected human immunodeficiency virus in critically ill emergency patients. JAMA 1987;257:2609-11.
107. Kelen GD, Fritz S, Qaqish B, et al. Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med 1988;318:1645-50.
108. Kaatz GW, Gitlin SD, Schaberg DR, et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988;127:1289-94.
109. McFarland LV, Mulligan ME, Kwok RYY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989;320:204-10.
110. Hughes CE, Gebhard RL, Peterson LR, Gerding DN. Efficacy of routine fiberoptic endoscope cleaning and disinfection for killing Clostridium difficile. Gastrointest Endosc 1986;32:7-9.
111. Dyas A, Das BC. The activity of glutaraldehyde against Clostridium difficile. J Hosp Infect 1985;6:41-5.
112. Brown P, Gibbs CJ, Amyx HL, et al. Chemical disinfection of Creutzfeldt-Jakob disease virus. N Engl J Med 1982; 306:1279-81.
113. Steelman VM. Creutzfeld-Jakob disease: recommendations for infection control. AJIC Am J Infect Control 1994;22:312-8.
114. Geertsma RE, van Asten JAAM. Sterilization of prions: requirements, implications, complications. J European Steril (in press).
115. Taylor DM. Inactivation of the unconventional agents of scrapie, bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. J Hosp Infect 1991;18(Suppl A): 141-6.
116. Rohwer RG. Scrapie infectious agent is virus-like in size and susceptibility to inactivation. Nature 1984;308:658-62.
117. Brown P, Rohwer RG, Gajdusek DC. Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus [letter]. N Engl J Med 1984;310:727.
118. American Neurological Association. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Ann Neurol 1986;19:75-7.
119. Brown P, Rohwer RG, Gajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986;153:1145-8.
120. Tamai Y, Taguchi F, Miura S. Inactivation of the Creutzfeld-Jakob disease agent. Ann Neurol 1988;24: 466-7.
121. Taguchi F, Tamai Y, Uchida K, et al. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent. Arch Virol 1991;119:297-301.
122. Kimberlin RH, Walker CA, Millson GC, et al. Disinfection studies with two strains of mouse-passaged scrapie agent: guidelines for Creutzfeldt-Jakob and related agents. J Neurol Sciences 1983;59:355-69.
123. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 1990;40:887-90.
124. Occupational Safety and Health Administration. Occupational exposure to bloodborne pathogens; final rule. Federal Register 1991;56:64003-182.
125. Occupational Safety and Health Administration. OSHA instruction CPL 2-2.44C. Washington, DC: Office of Health Compliance Assistance, Mar. 6 1992.
126. Chataigner D, Garnier R, Sans S, Efthymiou ML. Acute accidental poisoning with a hospital disinfectant: 45 cases, 13 deaths. Presse Med 1991;20:741-3.
127. Hess JA, Molinari JA, Gleason MJ, Radecki C. Epidermal toxicity of disinfectants. Am J Dent 1991;4:51-6.
128. Rutala WA. Selection and use of disinfectants in health care. In: Mayhall CG, ed. Hospital epidemiology and infection control. Baltimore: Williams and Wilkins 1996: 913-36.
129. Nystrom B. New technology for sterilization and disinfection. Am J Med 1991;91(suppl 3B):264S-266S.
130. Daschner F. The hospital and pollution: role of the hospital epidemiologist in protecting the environment. In: Wenzel RP, ed. Prevention and control of nosocomial infections. 2nd ed. Baltimore: Williams and Wilkins, 1993:993-1000.
131. Brumfitt W, Dixson S, Hamilton-Miller JMT. Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus. Lancet 1985;I:1442-3.
132. Al-Masaudi SB, Day MF, Russell AD. Sensitivity of methicillin-resistant Staphylococcus aureus strains to some antibiotics, antiseptics and disinfectants. J Appl Bacteriol 1988;65:329-37.
133. Townsend DE, Ashdown N, Greed LC, Grubb WB. Analysis of plasmids mediating gentamicin resistance in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1984;13:347-52.
134. Townsend DE, Greed L, Ashdown N, Grubb WB. Plasmid-mediated resistance to quaternary ammonium compounds in methicillin-resistant Staphylococcus aureus. Med J Australia 1983;ii:310.
135. Townsend DE, Ashdown N, Greed LC, Grubb WB. Transposition of gentamicin resistance to staphylococcal plasmids encoding resistance to cationic agents. J Antimicrob Chemother 1984;14:115-24.
136. Tennant JM, Lyon BR, Gillespie MT, May JW, Skurray RA. Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli. Antimicrob Agents Chemother 1985;27: 79-83.
137. Tennant JM, Lyon BR, Midgley M, Jones IG, Purewal AS, Skurray RA. Physical and biochemical characterization of the qacA gene encoding antiseptic and disinfectant resistance in Staphylococcus aureus. J Gen Microbiol 1989;135:1-10.
138. - strains of Escherichia coli to antibacterial agents and transfer of resistance to Pseudomonas aeruginosa. Current Microbiol 1979;3:89-94.
139. Kaulfers PM, Laufs R. Transmissible formaldehyde resistance in Serratia marcescens. Zbl Bakt Hyg I Abt Orig B 1985;181:309-19.
140. Sutton L, Jacoby GA. Plasmid-determined resistance to hexachlorophene in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1978;13:634-6.
141. Rutala WA, Stiegel MM, Sarubbi FA, Weber DJ. Ineffectiveness of disinfectants against hospital strains of bacteria. Infect Control Hosp Epidemiol (in press).
142. Anderson RL, Carr JH, Bond WW, Favero MS. Susceptibility of vancomycin-resistant enterococci to various hospital disinfectants. In: Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C., 1995:424.
143. Best M. Development of a combined carrier test for disinfectant efficacy. Ottawa, Ontario: University of Ottawa; 1994. Thesis.
144. Favero MS. Discussion. In: Chemical germicides in health care. Rutala WA, ed. Quebec: Polyscience Publications, 1995:84.
145. Hansen KS. Occupational dermatoses in hospital cleaning women. Contact Dermatitis 1983;9:343-51.
146. Melli MC, Giorgini S, Sertoli A. Sensitization from contact with ethyl alcohol. Contact Dermatitis 1986;14: 315.
147. Spaulding EH. Alcohol as a surgical disinfectant. AORN J 1964;2:67-71.
148. Morton HE. The relationship of concentration and germicidal efficiency of ethyl alcohol. Ann NY Acad Sci 1950;53:191-6.
149. Coulthard CE, Sykes G. The germicidal effect of alcohol with special reference to its action on bacterial spores. Pharm J 1936;137:79-81.
150. Smith CR. Alcohol as a disinfectant against the tubercle bacillus. Public Health Rep 1947;62:1285-95.
151. Kruse RH, Green TD, Chambers RC, Jones MW. Disinfection of aerosolized pathogenic fungi on laboratory surfaces:I - tissue phase. Appl Microbiol 1963;11:436-45.
152. Kruse RH, Green TD, Chambers RC, Jones MW. Disinfection of aerosolized pathogenic fungi on laboratory surfaces:II - culture phase. Appl Microbiol 1964;12:155-60.
153. Kurtz JB, Lee TW, Parsons AJ. The action of alcohols on rotavirus, astrovirus and enterovirus. J Hosp Infect 1980;1:321-5.
154. Connor CG, Hopkins SL, Salisbury RD. Effectivity of contact lens disinfection systems against Acanthamoeba culbertsoni. Optom Vis Sci 1991;68:138-41.
155. Nye RN, Mallory TB. A note on the fallacy of using alcohol for the sterilization of surgical instruments. Boston Med Surg J 1923;189:561-3.
156. Sommermeyer L, Frobisher M. Laboratory studies on disinfection of rectal thermometers. Nurs Res 1953;2: 85-9.
157. Frobisher M, Sommermeyer L, Blackwell MJ. Studies on disinfection of clinical thermometers:I - oral thermometers. Appl Microbiol 1953;1:187-94.
158. Babb JR, Bradley CR, Deverill CEA, Ayliffe GAJ, Melikian V. Recent advances in the cleaning and disinfection of fiberscopes. J Hosp Infect 1981;2:329-40.
159. Garcia de Cabo A, Larriba PLM, Pinilla JC, Sanz FG. A new method of disinfection of the flexible fibrebronchoscope. Thorax 1978;33:270-2.
160. Weber DJ, Wilson MB, Rutala WA, Thomann CA. Manual ventilation bags as a source for bacterial colonization of intubated patients. Am Rev Respir Dis 1990;142: 892-4.
161. Cavagnola RZ. Brief report: inactivation of herpesvirus on CPR manikins utilizing a currently recommended disinfecting procedure. Infect Control 1985;6:456-8.
162. Talbot GH, Skros M, Provencher M. 70% alcohol disinfection of transducer heads: experimental trials. Infect Control 1985;6:237-9.
163. Platt R, Lehr JL, Marino S, Munoz A, Nash B, Raemer DB. Safe and cost-effective cleaning of pressure monitoring transducers. Infect Control Hosp Epidemiol 1988; 9:409-16.
164. Beck-Sague CM, Jarvis WR. Epidemic bloodstream infections associated with pressure transducers: a persistent problem. Infect Control Hosp Epidemiol 1989;10: 54-9.
165. Chronister CL, Russo P. Effects of disinfecting solutions on tonometer tips. Optom Vis Sci 1990;67:818-21.
166. Lingel NJ, Coffey B. Effects of disinfecting solutions recommended by the Centers for Disease Control on Goldmann tonometer biprisms. J Am Optom Assoc 1992;63:43-8.
167. Soukiasian SH, Asdourian GK, Weiss JS, Kachadoorian HA. A complication from alcohol-swabbed tonometer tips. Am J Ophthalmol 1988;105:424-5.
168. Hoffman PN, Death JE, Coates D. The stability of sodium hypochlorite solutions. In: Collins CH, Allwood MC, Bloomfield SF, Fox A, eds. Disinfectants: their use and evaluation of effectiveness. London: Academic Press, 1981:77-83.
169. Dychdala GR. Chlorine and chlorine compounds. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:131-51.
170. Gamble MR. Hazard: formaldehyde and hypochlorites. Lab Anim 1977;11:61.
171. Coates D. Comparison of sodium hypochlorite and sodium dichloroisocyanurate disinfectants: neutralization by serum. J Hosp Infect 1988;11:60-7.
172. Coates D. A comparison of sodium hypochlorite and sodium dichloroisocyanurate products. J Hosp Infect 1985;6:31-40.
173. Coates D, Wilson M. Use of sodium dichloroisocyanurate granules for spills of body fluids. J Hosp Infect 1989;13: 241-51.
174. Bloomfield SF, Uso EE. The antibacterial properties of sodium hypochlorite and sodium dichloroisocyanurate as hospital disinfectants. J Hosp Infect 1985;6:20-30.
175. Lee DH, Miles RJ, Perry BF. The mycoplasmacidal properties of sodium hypochlorite. J Hyg Camb 1985;95: 243-53.
176. Williams ND, Russell AD. The effects of some halogen-containing compounds on Bacillus subtilis endospores. J Appl Bacteriol 1991;70:427-36.
177. Centers for Disease Control. Bacteremia associated with reuse of disposable hollow-fiber hemodialyzers. MMWR 1986;35:417-8.
178. Centers for Disease Control. Acquired immune deficiency syndrome (AIDS): precautions for clinical and laboratory staffs. MMWR 1982;31:577-80.
179. Garner JS, Simmons BP. Guideline for isolation precautions in hospitals. Infect Control 1983;4:245-325.
180. Bloomfield SF, Miller EA. A comparison of hypochlorite and phenolic disinfectants for disinfection of clean and soiled surfaces and blood spillages. J Hosp Infect 1989; 13:231-9.
181. Recommendations for decontaminating manikins used in cardiopulmonary resuscitation training 1983 update. Infect Control 1984;5:399-401.
182. Centers for Disease Control and Prevention. Use of bleach for disinfection of drug injection equipment. MMWR 1993;42:418-9.
183. Shapshak P, McCoy CB, Rivers JE, et al. Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach. J Acquir Immune Defic Syndr 1993;6:218-9.
184. Helms CM, Massanari RM, Zeitler R, et al. Legionnaires' disease associated with a hospital water system: a cluster of 24 nosocomial cases. Ann Intern Med 1983;99:172-8.
185. Steve L, Goodhart P, Alexander J. Hydrotherapy burn treatment: use of chloramine-T against resistant microorganisms. Arch Phys Med Rehabil 1979;60:301-3.
186. Turner AG, Higgins MM, Craddock JG. Disinfection of immersion tanks (Hubbard) in a hospital burn unit. Arch Environ Health 1974;28:101-4.
187. Rutala WA, Cole EC, Thomann CA, Weber DJ. Stability and bactericidal activity of chlorine solutions. Infect Control Hosp Epidemiol (in press).
188. Tulis JJ. Formaldehyde gas as a sterilant. In: Phillips GB, Miller WS, eds. Industrial sterilization. Durham: Duke University Press, 1972:209-38.
189. Rubbo SD, Gardner JF, Webb RL. Biocidal activities of glutaraldehyde and related compounds. J Appl Bacteriol 1967;30:78-87.
190. Emmons CW. Fungicidal action of some common disinfectants on two dermatophytes. Arch Dermatol Syph 1933;28:15-21.
191. McCulloch EC, Costigan S. A comparison of the efficiency of phenol, liquor cresolis, formaldehyde, sodium hypochlorite and sodium hydroxide against Eberthella typhi at various temperatures. J Infect Dis 1936;59:281-4.
192. National Institute for Occupational Safety and Health. NIOSH report: formaldehyde exposures in dialysis units. Dialysis Transplant 1983;12:43-4.
193. Centers for Disease Control. Occupational exposures to formaldehyde in dialysis units. MMWR 1986;35(24):399-401.
194. Centers for Disease Control. Formaldehyde exposures in a gross anatomy laboratory - Colorado. MMWR 1983; 31(52):698-700.
195. Tokars JI, Alter MJ, Favero JS, Moyer LA, Miller E, Bland LE. National surveillance of dialysis associated diseases in the United States, 1992. ASAIO J 1994;40:1020-31.
196. Favero MS, Altar MJ, Bland LA. Dialysis-associated disease and their control. In: Bennett JV, Brachman PS, eds. Hospital infections. 3rd ed. Boston: Little, Brown and Company, 1992:375-403.
197. Bland LA, Favero MS. Microbial contamination control strategies for hemodialysis systems. In: Plant, technology and safety management series: infection control issues in PTSM. Chicago: Joint Commission on Accreditation of Healthcare Organizations, Feb. 1990.
198. Boucher RMG. Potentiated acid 1,5 pentanedial solution - a new chemical sterilizing and disinfecting agent. Am J Hosp Pharm 1974;31:546-57.
199. Miner NA, McDowell JW, Willcockson GW, Bruckner NI, Stark RL, Whitmore EJ. Antimicrobial and other properties of a new stabilized alkaline glutaraldehyde disinfectant/sterilizer. Am J Hosp Pharm 1977;34:376-82.
200. Pepper RE. Comparison of the activities and stabilities of alkaline glutaraldehyde sterilizing solutions. Infect Control 1980;1:90-2.
201. Leach ED. A new synergized glutaraldehyde-phenate sterilizing solution and concentrated disinfectant. Infect Control 1981;2:26-30.
202. Miner NA, Ross C. Clinical evaluation of ColdSpor, a glutaraldehyde-phenolic disinfectant. Respir Care 1991; 36:104-9.
203. Babb JR, Bradley CR, Ayliffe GAJ. Sporicidal activity of glutaraldehydes and hypochlorites and other factors influencing their selection for the treatment of medical equipment. J Hosp Infect 1980;1:63-75.
204. Collins FM, Montalbine V. Mycobactericidal activity of glutaraldehyde solutions. J Clin Microbiol 1976;4:408-12.
205. Masferrer R, Marquez R. Comparison of two activated glutaraldehyde solutions: Cidex Solution and Sonacide. Respir Care 1977;22:257-62.
206. Scott EM, Gorman SP. Glutaraldehyde. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger 1991:596-614.
207. Stonehill AA, Krop S, Borick PM. Buffered glutaraldehyde - a new chemical sterilizing solution. Am J Hosp Pharm 1963;20:458-65.
208. Borick PM, Dondershine FH, Chandler VL. Alkalinized glutaraldehyde, a new antimicrobial agent. J Pharm Sci 1964;53:1273-5.
209. van Klingeren B, Pullen W. Glutaraldehyde resistant mycobacteria from endoscope washers. J Hosp Infect 1993;25:147-9.
210. Holten J, Nye P, McDonald V. Efficacy of selected disinfectants against Mycobacteria and Cryptosporidia. J Hosp Infection 1994;27:105-15.
211. Casemore DP. Cleaning and disinfection of equipment for gastrointestinal flexible endoscopy: interim recommendations of a Working Party of the British Society of Gastroenterology. Gut 1989;30:1156-9.
212. Townsend TR, Wee SB, Koblin B. An efficacy evaluation of a synergized glutaraldehyde-phenate solution in disinfecting respiratory therapy equipment contaminated during patient use. Infect Control 1982;3:240-3.
213. Husni L, Kale E, Climer C, Bostwick B, Parker TF. Evaluation of a new disinfectant for dialyzer reuse. Am J Kidney Dis 1989;14:110-8.
214. Rutala DR, Rutala WA, Weber DJ, Thomann CA. Infection risks associated with spirometry. Infect Control Hosp Epidemiol 1991;12:89-92.
215. Petersen NJ, Carson LA, Doto IL, Aguero SM, Favero MS. Microbiologic evaluation of a new glutaraldehyde-based disinfectant for hemodialysis systems. Trans Am Soc Artif Intern Organs 1982;28:287-90.
216. Mbithi JN, Springthorpe VS, Sattar SA, Pacquette M. Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit. J Clin Microbiol 1993;31:2988-95.
217. Leong D, Dorsey C, Klapp M. Dilution of glutaraldehyde by automatic endoscope machine washers: the need for a quality control program [Abstract]. AJIC Am J Infect Control 1987;15:86.
218. Kotilainen HR, Zanoli C, Lai KK. Glutaraldehyde concentration in automatic endoscope washers and monitoring systems [Abstract]. AJIC Am J Infect Control 1993;21:82.
219. Power EGM, Russell AD. Assessment of "cold Sterilog glutaraldehyde monitor." J Hosp Infect 1988;11:376-80.
220. Castelli M, Qizilbash A, Seaton T. Post-colonoscopy proctitis [Abstract]. Am J Gastroenterol 1986;81:887.
221. Dailey JR, Parnes RE, Aminlari A. Glutaraldehyde keratopathy. Am J Ophthalmol 1993;115:256-8.
222. Association for the Advancement of Medical Instrumentation. Safe use and handling of glutaraldehyde-based products in health care facilities. Arlington, VA. November 1995.
223. Wiggins P, McCurdy SA, Zeindenberg W. Epistaxis due to glutaraldehyde exposure. J Occup Med 1989;31:854-6.
224. Occupational Health Services. Material safety data sheet. New York: OHS, Apr. 14 1992.
225. Occupational Safety and Health Administration. Air contaminants; rule. Federal Register 1993;58:35338-51.
226. Rutala WA, Hamory BH. Expanding role of hospital epidemiology: employee health - chemical exposure in the health care setting. Infect Control Hosp Epidemiol 1989;10:261-6.
227. Occupational Safety and Health Administration. Air contaminants. Federal Register 1989;54:2464.
228. Centers for Disease Control. Symptoms of irritation associated with exposure to glutaraldehyde - Colorado. MMWR 1987;36:190-1.
229. Nethercott JR, Holness DL, Page E. Occupational contact dermatitis due to glutaraldehyde in health care workers. Contact Dermatitis 1988;18:193-6.
230. Corrado OJ, Osman J, Davies RJ. Asthma and rhinitis after exposure to glutaraldehyde in endoscopy units. Hum Toxicol 1986;5:325-7.
231. Schaeffer AJ, Jones JM, Amundsen SK. Bactericidal effect of hydrogen peroxide on urinary tract pathogens. Appl Environ Microbiol 1980;40:337-40.
232. Mentel R, Schmidt J. Investigations on rhinovirus inactivation by hydrogen peroxide. Acta Virol 1973;17:351-4.
233. Wardle MD and Renninger GM. Bactericidal effect of hydrogen peroxide on spacecraft isolates. Appl Microbiol 1975;30:710-1.
234. Turner FJ. Hydrogen peroxide and other oxidant disinfectants. In: Block SS, ed. Disinfection, sterilization and preservation. 3rd ed. Philadelphia: Lea & Febiger, 1983: 240-50.
235. Leaper S. Influence of temperature on the synergistic sporicidal effect of peracetic acid plus hydrogen peroxide on Bacillus subtilis SA22(NCA 72-52). Food Microbiol 1984;1:199-203.
236. Silvany RE, Dougherty JM, McCulley JP, Wood TS, Bowman RW, Moore MB. The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga. Ophthalmology 1990;97:286-90.
237. Moore MB. Acanthamoeba keratitis and contact lens wear: the patient is at fault. Cornea 1990;9(Suppl 1):S33-5.
238. Judd PA, Tomlin PJ, Whitby JL, Inglis TCM, Robinson JS. Disinfection of ventilators by ultrasonic nebulisation. Lancet 1968;2:1019-20.
239. Levenson JE. Corneal damage from improperly cleaned tonometer tips [Letter]. Arch Ophthalmol 1989;107:1117.
240. Maizels M, Schaeffer AJ. Decreased incidence of bacteriuria associated with periodic instillations of hydrogen peroxide into the urethral catheter drainage bag. J Urol 1980;123:841-5.
241. Thompson RL, Haley CE, Searcy MA, et al. Catheter-associated bacteriuria: failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA 1984;251:747-51.
242. Jonas G, Mahoney A, Murray J, Gertler S. Chemical colitis due to endoscope cleaning solutions: a mimic of pseudomembranous colitis. Gastroenterol 1988;95: 1403-8.
243. Bilotta JJ, Waye JD. Hydrogen peroxide enteritis: the "snow white" sign. Gastrointest Endosc 1989;35:428-30.
244. Gottardi W. Iodine and iodine compounds. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:152-66.
245. Craven DE, Moody B, Connolly MG, Kollisch NR, Stottmeier KD, McCabe WR. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 1981;305:621-3.
246. Berkelman RL, Lewin S, Allen JR, et al. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med 1981;95:32-6.
247. Parrott PL, Terry PM, Whitworth EN, et al. Pseudomonas aeruginosa peritonitis associated with contaminated poloxamer-iodine solution. Lancet 1982;2:683-5.
248. Favero MS. Iodine - champagne in a tin cup. Infect Control 1982;3:30-2.
249. Berkelman RL, Holland BW, Anderson RL. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 1982;15:635-9.
250. Chang SL. Modern concept of disinfection. J Sanit Eng Div Proc Am Soc Civ Eng 1971;689-705.
251. Wallbank AM, Drulak M, Poffenroth L, Barnes C, Kay C, Lebtag I. Wescodyne: lack of activity against poliovirus in the presence of organic matter. Health Lab Sci 1978;15: 133-7.
252. Sattar SA, Raphael RA, Lochnan H, Springthorpe VS. Rotavirus inactivation by chemical disinfectants and antiseptics used in hospitals. Can J Microbiol 1983;29: 1464-9.
253. Block SS. Peroxygen compounds. In: Block SS, ed. Disinfection, sterilization and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:167-81.
254. Lensing HH, Oei HL. Investigations on the sporicidal and fungicidal activity of disinfectants. Zentralbl Bakteriol Hyg [B] 1985;181:487-95.
255. Fleming SJ, Foreman K, Shanley K, Mihrshahi R, Siskind V. Dialyser reprocessing with renalin. Am J Nephrol 1991;11:27-31.
256. Held PJ, Wolfe RA, Gaylin DS, et al. Analysis of the Association of Dialyzer Reuse Practices and Patient Outcomes. Am J Kidney Dis 1994;23:692-708.
257. Crow S. Peracetic acid sterilization: a timely development for a busy healthcare industry. Infect Control Hosp Epidemiol 1992;13:111-3.
258. Bond WW. Biological indicators for a liquid chemical sterilizer: a solution to the instrument reprocessing problem? Infect Control Hosp Epidemiol 1993;14:309-12.
259. Kralovic RC. Use of biological indicators designed for steam or ethylene oxide to monitor a liquid chemical sterilization process. Infect Control Hosp Epidemiol 1993;14:313-9.
260. Seballos RJ, Walsh AL, Mehta AC. Clinical evaluation of a liquid chemical sterilization system for the flexible bronchoscope. J Bronchology 2;1995:192-9.
261. Wallace CG, Agee PM, Demicco DD. Liquid chemical sterilization using peracetic acid: an alternative approach to endoscope processing. ASAIO J 1995;41:151-4.
262. Bradley DR, Babb JR, Ayliffe GAJ. Evaluation of the Steris System 1 peracetic acid endoscope processor. J Hosp Infection. 1995;29:143-51.
263. Holton J, Shetty N, McDonald V. Efficacy of 'Nu-Cidex (0.35% peracetic acid) against mycobacteria and cryptosporidia. J Hosp Infect 1995;31:235-44.
264. Lynam PA, Babb JR, Fraise AP. Comparison of the mycobactericidal activity of 2% alkaline glutaraldehyde and 'Nu-Cidex (0.35% peracetic acid). J Hosp Infect 1995;30:237-40.
265. Kahn G. Depigmentation caused by phenolic detergent germicides. Arch Dermatol 1970;102:177-87.
266. Prindle RF. Phenolic compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. 3rd ed. Philadelphia: Lea & Febiger, 1983:197-224.
267. Hegna IK. A comparative investigation of the bactericidal and fungicidal effects of three phenolic disinfectants. J Appl Bacteriol 1977;43:177-81.
268. Hegna IK. An examination of the effect of three phenolic disinfectants on Mycobacterium tuberculosis. J Appl Bacteriol 1977;43:183-7.
269. Bergan T, Lystad A. Antitubercular action of disinfectants. J Appl Bacteriol 1971;34:751-6.
270. Narang HK, Codd AA. Action of commonly used disinfectants against enteroviruses. J Hosp Infect 1983;4:209-12.
271. Cole EC, Rutala WA, Samsa GP. Disinfectant testing using a modified use-dilution method: collaborative study. J Assoc Analytical Chemists 1988;71:1187-94.
272. Wysowski DK, Flynt JW, Goldfield M, Altman R, Davis AT. Epidemic neonatal hyperbilirubinemia and use of a phenolic disinfectant detergent. Pediatrics 1978;61:165-70.
273. Doan HM, Keith L, Shennan AT. Phenol and neonatal jaundice. Pediatrics 1979;64:324-5.
274. Plotkin SA, Austrian R. Bacteremia caused by Pseudomonas sp. following the use of materials stored in solutions of a cationic surface-active agent. Am J Med Sci 1958; 235:621-7.
275. Malizia WF, Gangarosa EJ, Goley AF. Benzalkonium chloride as a source of infection. N Engl J Med 1960; 263:800-2.
276. Lee JC, Fialkow PJ. Benzalkonium chloride - source of hospital infection with gram-negative bacteria. JAMA 1961;177:708-10.
277. Hardy PC, Ederer GM, Matsen JM. Contamination of commercially packaged urinary catheter kits with the Pseudomonad EO-1. N Engl J Med 1970;282:33-5.
278. Frank MJ, Schaffner W. Contaminated aqueous benzalkonium chloride: an unnecessary hospital infection hazard. JAMA 1976;236:2418-9.
279. Dixon RE, Kaslow RA, Mackel DC, Fulkerson CC, Mallison GF. Aqueous quaternary ammonium antiseptics and disinfectants: use and misuse. JAMA 1976;236: 2415-7.
280. Sautter RL, Mattman LH, Legaspi RC. Serratia marcescens meningitis associated with a contaminated benzalkonium chloride solution. Infect Cont 1984;5:223-5.
281. Nakashima AK, McCarthy MA, Martone WJ, Anderson RL. Epidemic septic arthritis caused by a Serratia marcescens and associated with a benzalkonium chloride antiseptic. J Clin Microbiol 1987;25:1014-8.
282. Shickman MD, Guze LB, Pearce ML. Bacteremia following cardiac catheterization. N Engl J Med 1959;260: 1164-6.
283. Ehrenkranz NJ, Bolyard EA, Wiener M, Cleary TJ. Antibiotic-sensitive Serratia marcescens infections complicating cardiopulmonary operations: contaminated disinfectant as a reservoir. Lancet 1980;2:1289-92.
284. Rutala WA, Cole EC. Antiseptics and disinfectants - safe and effective? Infect Control 1984;5:215-8.
285. Sykes G. Disinfection and sterilization. 2nd ed. London: E. & F.N. Spon, Ltd., 1965:362-76.
286. Petrocci AN. Surface active agents: quaternary ammonium compounds. In: Block SS, ed. Disinfection, sterilization, and preservation. 3rd ed. Philadelphia: Lea & Febiger, 1983:309-29.
287. Smith CR, Nishihara H, Golden F, Hoyt A, Guss CO, Kloetzel MC. The bactericidal effect of surface-active agents on tubercle bacilli. Public Health Rep 1950;48: 1588-600.
288. Alfa MJ, Sitter DL. In-hospital evaluation of orthophthaldehyde as a high level disinfectant for flexible endoscopes. J Hosp Infect 1994;26:15-26.
289. Schneider PM. Low-temperature sterilization alternatives in the 1990s. Tappi Journal 3424;77:115-9.
290. Environmental Protection Agency. Protection of stratospheric ozone; Proposed Rule. Federal Register. May 12, 1993.
291. Rutala WA, Weber, DJ. Low-temperature sterilization technologies: do we need to redefine "sterilization"? Infect Control Hosp Epidemiol 1996;17:87-91.
292. Gross D. Ethylene oxide sterilization and alternative methods. Surgical Services Management 1995;1:16-7.
293. Holler C, Martiny H, Barbel C, Ruden H, and Gundermann K. The efficacy of low temperature plasma (LTP) sterilization, a new sterilization technique. Zbl Hyg. 1993;194:380-91.
294. Alfa MJ, DeGagne P, Olson N, Puchalski T. Comparison of ion plasma, vaporized hydrogen peroxide and 100% ethylene oxide sterilizers to the 12/88 ethylene oxide gas sterilizer. Infect Control Hosp Epidemiol 1996;17:92-9.